Clinical Trial Update: Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial by The University of Hong Kong evaluating a GLP-1 receptor agonist to optimize obesity in patients undergoing total knee replace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: The University of Hong Kong | Conditions: Osteoarthritis (OA) of the Knee | EARLY_Phase 1 | Status: NOT_YET_RECRUITING